MENU
+Compare
XBIT
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$2.90
Change
+$0.04 (+1.40%)
Capitalization
86.89M

XBIT XBiotech Forecast, Technical & Fundamental Analysis

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for XBIT with price predictions
May 28, 2025

XBIT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for XBIT turned positive on May 13, 2025. Looking at past instances where XBIT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where XBIT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XBIT advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XBIT as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XBIT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XBIT entered a downward trend on May 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XBIT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.497) is normal, around the industry mean (16.080). P/E Ratio (0.000) is within average values for comparable stocks, (59.383). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.197). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (268.270).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XBIT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

XBIT paid dividends on July 23, 2021

XBiotech XBIT Stock Dividends
А quarterly dividend of $2.47 per share was paid with a record date of July 23, 2021, and an ex-dividend date of July 15, 2021. Read more...
A.I. Advisor
published General Information

General Information

a company that discovers and develops therapeutic antibodies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5217 Winnebago Lane
Phone
+1 512 386-2900
Employees
82
Web
http://www.xbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

XBIT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with GBIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
-1.69%
GBIO - XBIT
41%
Loosely correlated
-1.11%
NAUT - XBIT
39%
Loosely correlated
-3.95%
ABOS - XBIT
38%
Loosely correlated
N/A
GLSI - XBIT
38%
Loosely correlated
-2.61%
TECH - XBIT
37%
Loosely correlated
-1.56%
More